Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma.


Altuncu E., Berrak S., Bilgen H. S. , Yurdakul Z., Canpolat C., Oezek E.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, cilt.20, sa.8, ss.627-9, 2007 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Konu: 8
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1080/14767050701411935
  • Dergi Adı: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • Sayfa Sayıları: ss.627-9

Özet

Activated recombinant factor VIIa was administered to a preterm infant with bleeding diasthesis and a huge subdural hematoma that could not be controlled by the blood products. The coagulation tests were normalized the following day. Recombinant factor VIIa can be a choice in selected cases with intractable bleedings unesponsive to conventional replacement therapy.